Berry S A, Manthei R D, Seelig S
Endocrinology. 1986 Nov;119(5):2290-6. doi: 10.1210/endo-119-5-2290.
The ontogenesis of hepatic GH receptor content is postulated as a major determinant of expression of hepatic GH-responsive gene products, since the ontogeny of the receptors and the responsive gene products, somatomedin-C, somatomedin-binding protein, and GH-responsive acidic protein, have similar qualitatively ontogenetic patterns. Two-dimensional gel electrophoresis of in vitro synthesized [35S]methionine-labeled proteins formed in the cell-free mRNA-dependent rabbit reticulocyte lysate system in response to hepatic RNA was used to quantitate the ontogenetic changes in a family of five GH-responsive gene products (S3, S11, S15, S16, and S20). These gene products were altered 2- to 12-fold by the administration of methionyl-human GH to adult hypophysectomized animals and were not altered by the combined administration of T4, corticosterone, and dihydrotestosterone. The translational activity of three of the five products (S3, S15, and S20) in animals younger than 15 days ranged from 1-12% of the values observed in normal adults and was consistent with diminished GH action. The translational activities of two mRNA sequences (S11 and S16) were not consistent with diminished GH action in the newborn animal. In the newborn animal, S11, induced 3-fold by GH in the adult animal, was 7.4 times the level observed in the adult. During the time of increasing GH receptor content (2-35 days), S16, attenuated by GH 2-fold in the adult, increased 6-fold. Injection of GH from days 2 through 11 augmented S20 and D2 (a hormonally nonresponsive, developmentally dependent product) 2-fold. The combined administration from days 2 through 11 of GH, T4, and corticosterone augmented S16 1.8-fold, a response paradoxical to that in the adult animal, but consistent with advancing maturation of the liver. We conclude that GH receptor content is not the sole determinant for the ontogenetic expression of GH-responsive products and that important alternate mechanisms exist for their regulation. In addition, GH, along with T4 and corticosterone, appear to modulate the rate at which adult levels of some mRNA sequences are achieved.
肝脏生长激素(GH)受体含量的个体发生被假定为肝脏中GH反应性基因产物表达的主要决定因素,因为受体以及反应性基因产物(胰岛素样生长因子 - C、胰岛素样生长因子结合蛋白和GH反应性酸性蛋白)的个体发生在质量上具有相似的个体发育模式。利用无细胞的依赖mRNA的兔网织红细胞裂解物系统,对响应肝脏RNA而在体外合成的[³⁵S]甲硫氨酸标记蛋白进行二维凝胶电泳,以定量一组5种GH反应性基因产物(S3、S11、S15、S16和S20)的个体发育变化。给成年垂体切除动物注射甲硫氨酰 - 人GH后,这些基因产物改变了2至12倍,而联合给予甲状腺素(T4)、皮质酮和二氢睾酮则不会改变它们。在15日龄以下的动物中,5种产物中的3种(S3、S15和S20)的翻译活性范围为正常成年动物中观察值的1%至12%,这与GH作用减弱一致。两种mRNA序列(S11和S16)的翻译活性与新生动物中GH作用减弱不一致。在新生动物中,S11在成年动物中被GH诱导3倍,其水平是成年动物中观察到的7.4倍。在GH受体含量增加的时期(2至35天),S16在成年动物中被GH减弱2倍,但增加了6倍。从第2天至第11天注射GH使S20和D2(一种激素无反应、发育依赖性产物)增加了2倍。从第2天至第11天联合给予GH、T4和皮质酮使S16增加了1.8倍,这一反应与成年动物中的情况相反,但与肝脏成熟进展一致。我们得出结论,GH受体含量不是GH反应性产物个体发育表达的唯一决定因素,并且存在重要的替代调节机制。此外,GH与T4和皮质酮一起,似乎调节了一些mRNA序列达到成年水平的速率。